siRNA-Mediated Transcription Factor Knockdown for Cell Reprogramming
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reprogramming somatic cells into induced pluripotent stem cells (iPSCs) face low efficiency and safety concerns due to the use of viral vectors and oncogenes, with existing chemical reprogramming strategies achieving reprogramming efficiencies of only around 0.2%-0.8%.
Innovation Solution
The use of siRNA or shRNA molecules to transiently inhibit specific lineage-defining transcription factors such as SNAI2, PRRX1, and CDX2 in somatic fibroblast cells, allowing for transdifferentiation to alternate lineages or dedifferentiation to pluripotent stem cells without the need for exogenous transcription factors or small molecule modulators, thereby overcoming molecular safeguards and enhancing reprogramming efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If viral vectors or exogenous transcription factors are used for reprogramming, then reprogramming can be achieved, but safety concerns arise due to oncogenes and permanent genetic modification
Solution Approach 1:
The invention extracts and removes the harmful elements (viral vectors, exogenous transcription factors, oncogenes) from the reprogramming process while retaining the essential reprogramming function through endogenous factor modulation, thereby improving safety without requiring complex delivery systems
Solution Approach 2:
The method enables cells to reprogram themselves using their own endogenous transcription factors that are naturally present but suppressed, eliminating the need for external agents and permanent genetic modification, thus improving safety and reducing complexity
2Reliability
If chemical reprogramming with small molecule cocktails is used, then viral delivery risks are avoided, but reprogramming efficiency remains extremely low at around 0.2%
Solution Approach 1:
The invention changes the key parameter from external chemical modulation to endogenous transcriptional regulation by suppressing specific repressors, thereby dramatically improving reprogramming efficiency from 0.2% to over 1% while maintaining the safety advantages of chemical-free approaches
Solution Approach 2:
Instead of adding external factors to promote reprogramming, the invention inverts the approach by removing suppressive endogenous factors (through siRNA/shRNA-mediated silencing of lineage-defining transcription factors), allowing natural reprogramming to occur at high efficiency
3Productivity
If OSKM transcription factors are used for reprogramming, then iPSC generation is achieved, but reprogramming efficiency is limited to 0.2%-0.8%
Solution Approach 1:
The invention extracts the essential reprogramming function from the complex OSKM factor delivery system and achieves it through simple siRNA/shRNA-mediated silencing of endogenous repressors, dramatically improving efficiency to over 1% while eliminating the need for complex viral or non-viral delivery systems
Solution Approach 2:
The method leverages the cell's own endogenous transcription factors that are naturally present but suppressed by lineage-defining factors, allowing the cell to self-reprogram without external factor delivery, thus improving efficiency and reducing complexity simultaneously
4Productivity
If transient inhibition of lineage-defining transcription factors is performed, then reprogramming efficiency exceeds 1%, but permanent genetic modification is avoided
Solution Approach 1:
The invention uses transient, periodic siRNA/shRNA treatment to temporarily silence lineage-defining transcription factors only during the reprogramming window, achieving over 1% efficiency while allowing chromosomal stability to be maintained through the temporary nature of the intervention, producing pure and chromosomally stable cells
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves reprogramming efficiencies greater than 1%, generating pure and chromosomally stable transdifferentiated or dedifferentiated cells that can be used in tissue reconstruction, wound healing, and transplantation procedures without permanent genetic modification or the risks associated with viral delivery.
Implementation Method 1
The use of siRNA or shRNA molecules to transiently inhibit specific lineage-defining transcription factors such as SNAI2, PRRX1, and CDX2 in somatic fibroblast cells
Data Source
AI summary
Induced overexpression of defined exogenous transcription factors (TFs), or alternatively treatment with specific pathway modulatory cocktails, can reprogram somatic cells to pluripotency or alternate cell states. A barrier to initiating reprogramming lies in the starting cell's molecular identity, enforced by lineage-instructive TFs. However, it remained unclear whether repression of such somatic lineage-defining TFs of the starting cell in the absence of exogenous TFs is sufficient to induce cell reprogramming Using an intra-species somatic cell hybrid model, SNAI2 and PRRX1 were identified as the most critical determinants of mesenchymal commitment in rat embryonic fibroblasts (REFs) and demonstrate that siRNA-mediated transient knockdown of these individual factors is adequate to convert REFs into functional adipocytes, chondrocytes or osteocytes without requiring the provision of exogenous TFs. Additionally, it was shown that siRNA-mediated transient knockdown of SNAI2 alone, in the absence of exogenous TFs, is sufficient to transform REFs to a dedifferentiated pluripotent stem-like cell (dPSC) state that forms embryoid bodies and is capable of triple germ layer differentiation. These results establish for the first time that transient repression of a single somatic lineage-defining TF can effectively induce transdifferentiation to alternative somatic cell states or dedifferentiation to dPSCs in the absence of exogenous TFs or small molecule cocktails.